ALISO VIEJO, Calif., Feb. 09, 2017 -- NVISION Eye Centers—a national leader in providing the finest suite of ophthalmology services for patients including: custom and Topographic LASIK, KAMRA Inlay, cataract surgery and other vision correction procedures—is pleased to announce today the promotion of Brooke Jakovich to Vice President of Operations.
"Brooke has been an exemplary team player at NVISION Eye Centers, embracing every challenge put before her and excelling in many key roles within the organization,” says NVISION Eye Centers' president James Pereyra. "Since first joining the company as an Area Manager supporting our Fullerton location, she has demonstrated a strong aptitude for partnering with referring doctors, patients and teammates. Her breadth and depth of experience within the company, is proof of her commendable abilities not only as a team player, but also a true leader."
Over the course of ten years, Jakovich has held many positions with NVISION from managing the organization’s largest practice and flagship location in Newport Beach, California, to launching NVISION’s cataract service line in 2012. Most recently, she joined the leadership team as the head of operations where she was responsible for creating better communication channels between the clinics and support center, establishing mentorship and training programs, and developing the tools to support the Executive Directors in their respective clinics.
“This is an exciting time to be at NVISION, and I am honored to be taking the reins in this leadership capacity,” says Brooke Jakovich. “Beginning my professional career trajectory at NVISION afforded me a unique and insightful understanding of the inner workings of the company, from a tactical perspective. I look forward to helping my team cultivate new business opportunities and continue to grow within this thriving industry.”
Jakovich received her BA from California Sate University, Fullerton, graduating summa cum laude.
For more information, call (877) 455-9942 or visit: http://www.nvisioncenters.com.
ABOUT NVISION EYE CENTERS: NVISION Eye Centers is the premier provider of LASIK and cataract surgery in the U.S., with centers in California, Nevada, Oregon, Arizona and Toronto, Canada. An innovative leader in ophthalmology, NVISION is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 100,000 procedures throughout his esteemed career. With more than 1,900 eye doctors referring their patients and trusting their own eyes to NVISION surgeons, NVISION Eye Centers is the Eye Doctors' #1 Choice®. For more information, visit www.NVISIONCenters.com or call (877) 455-9942.


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



